DOUGLAS SEVERANCE: Open Payments
NPI 1639289838 · SAN RAMON, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,640 in 84 payments from 20 companies in 2025. Trend: 2023 $2,350 · 2024 $2,222 · 2025 $1,640
Food & beverage: $1,640
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 33 | $403 |
| Lilly USA, LLC | 7 | $186 |
| AstraZeneca Pharmaceuticals LP | 6 | $152 |
| Exact Sciences Corporation | 4 | $109 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $108 |
| Amgen Inc. | 4 | $95 |
| ABBVIE INC. | 3 | $81 |
| Indivior Inc. | 3 | $72 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $63 |
| Kowa Pharmaceuticals America, Inc. | 3 | $61 |
Products named: Ozempic, JARDIANCE, MOUNJARO, OTEZLA, The Cologuard Plus Collection Kit, FARXIGA, Wegovy, SUBLOCADE.
Industry payments across CA — which companies pay providers there.
